Simon Rolland, Najiby Kassis-Chikhani, Edouard Auclin, Samuel Bensaid, Anne-Laure Bidaud, Marie-Paule Gerlinger, Damien Blez, Jean-Luc Mainardi, David Lebeaux, Marie Dubert
We aimed to describe the outcome of totally implantable venous-access port (TIVAP)-related infections due to Gram-negative aerobic bacilli (Pseudomonas aeruginosa and other Pseudomonas spp., Acinetobacter spp., and Stenotrophomonas maltophilia), or GNAB, and assess the safety of conservative treatment. We conducted a retrospective study in a French teaching hospital, from January 2016 to December 2020, including adult patients treated for TIVAP-related infection due to GNAB. Success of conservative treatment was defined as a functional TIVAP 3 months after infection with no recurrence...
February 2023: European Journal of Clinical Microbiology & Infectious Diseases